Tested Applications
| Positive IHC detected in | human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16722-1-AP targets TMEM71 in IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag10161 Product name: Recombinant human TMEM71 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-167 aa of BC105783 Sequence: MYRISQLMSTPVASSSRLEREYAGELSPTCIFPSFTCDSLDGYHSFECGSIDPLTGSHYTCRRSPRLLTNGYYIWTEDSFLCDKDGNITLNPSQTSVMYKENLVRIFRKKKRICHSFSSLFNLSTSKSWLHGSIFGDINSSPSEDNWLKGTRRLDTDHCNGNETRLL Predict reactive species |
| Full Name | transmembrane protein 71 |
| Calculated Molecular Weight | 232 aa, 26 kDa |
| GenBank Accession Number | BC105783 |
| Gene Symbol | TMEM71 |
| Gene ID (NCBI) | 137835 |
| RRID | AB_2878304 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q6P5X7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TMEM71 is a transmembrane protein which was found to be associated with the glucocorticoids (GC) response status of the Acute Graft-versus-Host Disease (aGvHD) patients.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for TMEM71 antibody 16722-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TMEM71 Polyclonal antibody (Cat# 16722-1-AP) has 1 citation to date. It was used in a study published in Human Cell (2022) investigating an m6A-related gene signature for predicting prognosis and evaluating immune features in breast cancer. The antibody was applied via IHC in human samples, placing its cited research within the fields of oncology, RNA modification (m6A), and tumor immunology.
| Species | Application | Title |
|---|---|---|
Hum Cell Identification and validation of an m6A-related gene signature to predict prognosis and evaluate immune features of breast cancer |



